Literature DB >> 12853162

CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction.

Jana Petrkova1, Zuzana Cermakova, Jiri Drabek, Jan Lukl, Martin Petrek.   

Abstract

Examining an association between myocardial infarction (MI) and the Val/Ile polymorphism in the gene for CC chemokine receptor (CCR)2 at the position 64 (CCR2-V64I), 122 MI Czech patients and 277 unrelated control (C) subjects were genotyped by PCR-SSP. The frequency of the VI genotype of CCR2-V64I was increased in MI patients in comparison with the control population (P=0.03). Further analysis revealed that relationship between the VI genotype and MI is specific only for females and, strikingly, this genotype was associated to an early MI onset (before or at the age of 50 years). Females with the VI genotype were seven times more prone to suffer from MI before 50 years than those with the VV genotype (P<0.01). If the VI genotype of the CCR2-V64I is indeed a risk factor for an earlier MI onset in females must be checked by independent studies in other centres and/or populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853162     DOI: 10.1016/s0165-2478(03)00053-1

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.

Authors:  Hsiu-Ling Lin; Kwo-Chang Ueng; Yih-Shou Hsieh; Whei-Ling Chiang; Shun-Fa Yang; Shu-Chen Chu
Journal:  Mol Biol Rep       Date:  2012-07-03       Impact factor: 2.316

2.  Impact of CCL2 and Its Receptor CCR2 Gene Polymorphism in North Indian Population: A Comparative Study in Different Ethnic Groups Worldwide.

Authors:  Vibha Singh; Neena Srivastava; Priyanka Srivastava; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2012-10-05

3.  Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.

Authors:  Paul A Nyquist; Cherie A Winkler; Louise M McKenzie; Lisa R Yanek; Lewis C Becker; Diane M Becker
Journal:  Cerebrovasc Dis       Date:  2009-06-05       Impact factor: 2.762

4.  RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women.

Authors:  Jyh-Ming Liou; Jaw-Town Lin; Shih-Pei Huang; Chun-Ying Wu; Hsiu-Po Wang; Yi-Chia Lee; Han-Mo Chiu; Chia-Tung Shun; Ming-Tsan Lin; Ming-Shiang Wu
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

5.  Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population.

Authors:  Nan Zhao; Xin Liu; Yongqin Wang; Xiaoqiu Liu; Jiana Li; Litian Yu; Liyuan Ma; Shuyu Wang; Hongye Zhang; Lisheng Liu; Jingbo Zhao; Xingyu Wang
Journal:  J Neuroinflammation       Date:  2012-07-06       Impact factor: 8.322

6.  Touch of chemokines.

Authors:  Xavier Blanchet; Marcella Langer; Christian Weber; Rory R Koenen; Philipp von Hundelshausen
Journal:  Front Immunol       Date:  2012-07-12       Impact factor: 7.561

Review 7.  Mechanisms of Regulation of the Chemokine-Receptor Network.

Authors:  Martin J Stone; Jenni A Hayward; Cheng Huang; Zil E Huma; Julie Sanchez
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

8.  Combinations of Polymorphic Markers of Chemokine Genes, Their Receptors and Acute Phase Protein Genes As Potential Predictors of Coronary Heart Diseases.

Authors:  T R Nasibullin; L F Yagafarova; I R Yagafarov; Y R Timasheva; V V Erdman; I A Tuktarova; O E Mustafina
Journal:  Acta Naturae       Date:  2016 Jan-Mar       Impact factor: 1.845

9.  CCL2 Serum Levels and Adiposity Are Associated with the Polymorphic Phenotypes -2518A on CCL2 and 64ILE on CCR2 in a Mexican Population with Insulin Resistance.

Authors:  Milton-Omar Guzmán-Ornelas; Marcelo Heron Petri; Mónica Vázquez-Del Mercado; Efraín Chavarría-Ávila; Fernanda-Isadora Corona-Meraz; Sandra-Luz Ruíz-Quezada; Perla-Monserrat Madrigal-Ruíz; Jorge Castro-Albarrán; Flavio Sandoval-García; Rosa-Elena Navarro-Hernández
Journal:  J Diabetes Res       Date:  2015-12-29       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.